Gene delivery to hypoxic cells in vitro
2000
Gene Delivery to Hypoxic Cells in Tumors
publication
Evidence: moderate
Author Information
Author(s): Dachs G U, Coralli C, Hart S L, Tozer G M
Primary Institution: Tumour Microcirculation Group, Gray Laboratory Cancer Research Trust
Hypothesis
Can gene delivery be effectively achieved in hypoxic tumor cells?
Conclusion
The study demonstrated that hypoxic cells can be transfected with DNA, which is promising for future gene therapy strategies targeting hypoxia.
Supporting Evidence
- Hypoxia in tumors is linked to poor treatment outcomes.
- Hypoxic cells can be transfected with DNA using a non-viral system.
- Transfection efficiency varies with the level of hypoxia and cell type.
- Chronic anoxia significantly reduces transfection efficiency.
Takeaway
Scientists found a way to deliver genes to cancer cells that are low on oxygen, which could help treat tumors better.
Methodology
DNA was delivered in vitro using a peptide-mediated non-viral system across various oxygen levels and cell types.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website